Q32 Bio Inc.
QTTB
$1.74
$0.084.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.34% | 11.18% | -66.68% | -- | -- |
| Total Depreciation and Amortization | -2.42% | -2.40% | -2.39% | -- | -- |
| Total Amortization of Deferred Charges | 134.07% | 122.99% | 113.41% | -- | -- |
| Total Other Non-Cash Items | 163.47% | -235.04% | -231.77% | -- | -- |
| Change in Net Operating Assets | -135.25% | -136.62% | -87.22% | -- | -- |
| Cash from Operations | -216.64% | -262.56% | -4,400.51% | -- | -- |
| Capital Expenditure | -- | -1,400.00% | -1,360.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20,418.56% | -- | -- | -- | -- |
| Cash from Investing | 20,341.24% | 398,600.00% | 142,235.71% | -- | -- |
| Total Debt Issued | -525.26% | -939.24% | -68.42% | -- | -- |
| Total Debt Repaid | 154.08% | 154.08% | -13.50% | -- | -- |
| Issuance of Common Stock | -95.98% | 41,120.75% | 144,743.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.72% | -- | -- | -- | -- |
| Cash from Financing | -104.22% | 23,333.00% | 458.32% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.24% | 359.07% | 157.54% | -- | -- |